For US Residents Only View Healthcare Professional Site >
Important Safety Information Full Prescribing Information View​ HCP Site

Deprecated: Function wp_img_tag_add_loading_attr is deprecated since version 6.3.0! Use wp_img_tag_add_loading_optimization_attrs() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_get_loading_attr_default is deprecated since version 6.3.0! Use wp_get_loading_optimization_attributes() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_img_tag_add_loading_attr is deprecated since version 6.3.0! Use wp_img_tag_add_loading_optimization_attrs() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_get_loading_attr_default is deprecated since version 6.3.0! Use wp_get_loading_optimization_attributes() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_img_tag_add_loading_attr is deprecated since version 6.3.0! Use wp_img_tag_add_loading_optimization_attrs() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_get_loading_attr_default is deprecated since version 6.3.0! Use wp_get_loading_optimization_attributes() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_img_tag_add_loading_attr is deprecated since version 6.3.0! Use wp_img_tag_add_loading_optimization_attrs() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_get_loading_attr_default is deprecated since version 6.3.0! Use wp_get_loading_optimization_attributes() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_img_tag_add_loading_attr is deprecated since version 6.3.0! Use wp_img_tag_add_loading_optimization_attrs() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_get_loading_attr_default is deprecated since version 6.3.0! Use wp_get_loading_optimization_attributes() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_img_tag_add_loading_attr is deprecated since version 6.3.0! Use wp_img_tag_add_loading_optimization_attrs() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_get_loading_attr_default is deprecated since version 6.3.0! Use wp_get_loading_optimization_attributes() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_img_tag_add_loading_attr is deprecated since version 6.3.0! Use wp_img_tag_add_loading_optimization_attrs() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_get_loading_attr_default is deprecated since version 6.3.0! Use wp_get_loading_optimization_attributes() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_img_tag_add_loading_attr is deprecated since version 6.3.0! Use wp_img_tag_add_loading_optimization_attrs() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_get_loading_attr_default is deprecated since version 6.3.0! Use wp_get_loading_optimization_attributes() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_img_tag_add_loading_attr is deprecated since version 6.3.0! Use wp_img_tag_add_loading_optimization_attrs() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_get_loading_attr_default is deprecated since version 6.3.0! Use wp_get_loading_optimization_attributes() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_img_tag_add_loading_attr is deprecated since version 6.3.0! Use wp_img_tag_add_loading_optimization_attrs() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_get_loading_attr_default is deprecated since version 6.3.0! Use wp_get_loading_optimization_attributes() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_img_tag_add_loading_attr is deprecated since version 6.3.0! Use wp_img_tag_add_loading_optimization_attrs() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

Deprecated: Function wp_get_loading_attr_default is deprecated since version 6.3.0! Use wp_get_loading_optimization_attributes() instead. in /www/illuccixpersonal_557/public/wp-includes/functions.php on line 6031

What to expect from your imaging experience with Illuccix®

Preparing for your scan with Illuccix

If you are scheduled to have a scan, your doctor or a member of your care team will review specific preparation instructions with you, which may include:

Drink Plenty of Water: Make sure to hydrate with plenty of water before your scan appointment. Continue to drink water and urinate frequently after you receive the injection for your scan

Avoid Exercise: Try not to do strenuous exercise for at least 24 hours before the scan

Diet: Ask your doctor or care team about any foods or beverages you should avoid before your scan

Actor portrayal.

What to expect with Illuccix during your imaging appointment

When you arrive for your appointment, your doctor or a member of your care team will prepare you for the scan.

Below are some of the steps you can expect during your visit.

You will receive an intravenous or IV injection

You will be positioned on your back with your arms above your head for the scan

You will be asked to wait about an hour for the solution to make its way through your body and attach itself to any prostate-specific membrane antigen (PSMA) cells

You will be instructed to lie still for the scan and breathe normally. Someone from the care team will be there to assist you

You will likely be asked to urinate right before the scan

The scan time can vary, but usually takes about 30 minutes

What to expect after your scan with Illuccix

You should continue to drink water and empty your bladder for several hours after the appointment

Your doctor will contact you as soon as possible to discuss your scan results

Actor portrayal.

Understanding side effects

In clinical studies, the most common side effects included fatigue, nausea, diarrhea, constipation, vomiting, and dizziness.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch at www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report adverse reactions to Telix by calling 1-844-455-8638 or emailing pharmacovigilance@telixpharma.com.

Warnings and precautions →

Indications and Usage

ILLUCCIX, after radiolabeling with GA 68, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer:

  • With suspected metastasis who are candidates for initial definitive therapy
  • With suspected recurrence based on elevated serum prostate-specific antigen (PSA) level
  • For selection of patients with metastatic prostate cancer, for whom lutetium Lu 177 vipivotide tetraxetan PSMA-directed therapy is indicated

Important Safety Information

Warnings and Precautions

Risk for Misinterpretation

Image interpretation errors can occur with ILLUCCIX PET. A negative image does not rule out the presence of prostate cancer, and a positive image does not confirm the presence of prostate cancer. Gallium Ga 68 gozetotide uptake is not specific for prostate cancer and may occur with other types of cancer as well as non-malignant processes such as Paget’s disease, fibrous dysplasia, and osteophytosis. Clinical correlation, which may include histopathological evaluation of the suspected prostate cancer site, is recommended.

Indications and Usage

ILLUCCIX, after radiolabeling with GA 68, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer:

  • With suspected metastasis who are candidates for initial definitive therapy
  • With suspected recurrence based on elevated serum prostate-specific antigen (PSA) level
  • For selection of patients with metastatic prostate cancer, for whom lutetium Lu 177 vipivotide tetraxetan PSMA-directed therapy is indicated

Important Safety Information

Warnings and Precautions

Risk for Misinterpretation

Image interpretation errors can occur with ILLUCCIX PET. A negative image does not rule out the presence of prostate cancer, and a positive image does not confirm the presence of prostate cancer. Gallium Ga 68 gozetotide uptake is not specific for prostate cancer and may occur with other types of cancer as well as non-malignant processes such as Paget’s disease, fibrous dysplasia, and osteophytosis. Clinical correlation, which may include histopathological evaluation of the suspected prostate cancer site, is recommended.

Imaging Prior to Initial Definitive or Suspected Recurrence Therapy

The performance of ILLUCCIX for imaging of biochemically recurrent prostate cancer seems to be affected by serum PSA levels and by site of disease. The performance of ILLUCCIX for imaging of metastatic pelvic lymph nodes prior to initial definitive therapy seems to be affected by Gleason score.

Imaging to Select Patients for Lutetium Lu 177 Vipivotide Tetraxetan Therapy

The interpretation of ILLUCCIX PET may differ depending on imaging readers. ILLUCCIX PET interpretations to select patients for lutetium Lu 177 vipivotide tetraxetan therapy may be more consistent when judging gallium Ga 68 gozetotide uptake in any one tumor lesion compared to judging uptake for all lesions larger than size criteria. Multidisciplinary consultation to select patients for lutetium Lu 177 vipivotide tetraxetan therapy is recommended, particularly for ILLUCCIX imaging that a single reader finds borderline or difficult to interpret, or when patient eligibility hinges only on judgment of gallium Ga 68 gozetotide uptake for all lesions larger than size criteria.

Radiation Risks

Gallium Ga 68 gozetotide contributes to a patient’s overall long-term cumulative radiation exposure. Long-term cumulative radiation exposure is associated with an increased risk for cancer. Ensure safe handling to minimize radiation exposure to the patient and healthcare providers. Advise patients to hydrate before and after administration and to void frequently after administration.

Adverse Reactions

The safety of gallium Ga 68 gozetotide was evaluated in 960 patients in clinical studies, each receiving one dose of gallium Ga 68 gozetotide. The most commonly reported adverse reactions were nausea, diarrhea, and dizziness, occurring at a rate of <1%.

In a clinical study, 1003 patients received one dose of gallium Ga 68 gozetotide injection. Adverse reactions occurring at ≥0.5% in patients with metastatic prostate cancer who received gallium Ga 68 gozetotide injection in the clinical study were fatigue (1.2%), nausea (0.8%), constipation (0.5%), and vomiting (0.5%).

Adverse reactions occurring at a rate of <0.5% were diarrhea, dry mouth, injection site reactions, and chills, including injection site hematoma and injection site warmth and chills.

Drug Interactions

Androgen deprivation therapy and other therapies targeting the androgen pathway

Androgen deprivation therapy (ADT) and other therapies targeting the androgen pathway, such as androgen receptor antagonists, can result in changes in uptake of gallium Ga 68 gozetotide in prostate cancer. The effect of these therapies on performance of gallium Ga 68 gozetotide PET has not been established.

The safety information provided here is not complete. To learn more, talk about ILLUCCIX with your healthcare provider or pharmacist. The FDA-approved product labeling can be found at illuccix.com.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch at www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report adverse reactions to Telix by calling 1-844-455-8638 or emailing pharmacovigilance@telixpharma.com.

Please see the Full Prescribing Information.

Privacy Policy Terms of Use Contact Us About Telix

Illuccix® is a registered trademark of Telix Pharmaceuticals (US) Inc.
© 2023 Telix Pharmaceuticals (US) Inc. All rights reserved.
US-2100028v2 03/2022

Logo for Telix Pharmaceuticals
Logo for Telix Pharmaceuticals